Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Gsk Plc ADR (NY: GSK )

40.29 -0.47 (-1.15%)
Streaming Delayed Price Updated: 1:49 PM EDT, Jun 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Gsk Plc ADR

< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
29 30 Next >
Why Is Bellus Health (BLU) Stock Up 98% Today?
Bellus Health (BLU) stock is taking off on Tuesday after the company announced a $2 billion acquisition deal with GSK (GSK). 
Via InvestorPlace
GSK To Strengthen Specialty Medicines and Respiratory Pipeline With $2B BELLUS Health Acquisition
Via Benzinga
This Favorable Sign Appears On GSK's Chart
Via Benzinga
Can Pfizer Beat GSK and Moderna in This $10 Billion Market?
There's such a big need in preventing RSV that multiple companies should be big winners. 
Via The Motley Fool
Why Shares of Adaptimmune Therapeutics Jumped Tuesday
The company bulks up its pipeline by regaining the rights to two of its clinical programs. 
Via The Motley Fool
Biden Administration Launches $5B Program To Boost Development Of Pan-Coronavirus Vaccine, Treatments
The White House plans to devote $5 billion to develop effective treatments and vaccines against current and future Covid variants, a Department of Health and Human Services (HHS) spokesperson and a... 
Via Benzinga
This House of Representative Just Sold Up To $100K In GSK Stock
Via Benzinga
GSK Bets On Scynexis' FDA-Approved Antifungal Drug For Over $500M In Bio Bucks
Via Benzinga
GSK Stock Skids On Judge's New Ruling As Zantac Trial Looms
A trial this summer will examine one Zantac user's cancer. 
Via Investor's Business Daily
2 Top Biotech Stocks to Buy in April
Right now you can pick up these stocks on the dip. 
Via The Motley Fool
Could This Move by Johnson & Johnson Equal Billions for Moderna?
An RSV vaccine could be a driver of blockbuster revenue. 
Via The Motley Fool
Texas Judge Obstructs Affordable Act Coverage Mandate For Some Cancer Screenings, Prophylaxis
A Texas federal judge reportedly blocked Obamacare's mandate that health insurance plans cover preventive care, including screenings for certain cancers and pre-exposure prophylaxis against HIV (PrEP),... 
Via Benzinga
Stage Set For Generics As Biden Admin Asks Supreme Court To Hear Skinny Labels Case Between GSK, Teva
Via Benzinga
Why Is Scynexis (SCYX) Stock Up 69% Today?
Scynexis (SCYX) stock is taking off on Tuesday as investors react to news of an exclusive license agreement for Brexafemme. 
Via InvestorPlace
This Is What Whales Are Betting On GSK
Via Benzinga
Daily Stock Analysis: GSK
By my dogcatcher ideal, this is a proper time to buy GSK shares, based on their dividends for 2023. 
Via Talk Markets
How Is The Market Feeling About GSK?
Via Benzinga
Viatris Among Three Companies Licensed To Make GSK/Pfizer-Backed Long Acting HIV Prevention Drug
Via Benzinga
Johnson & Johnson Pulls Plug On Large Late-Stage Study Of RSV Vaccine Candidate; GSK, Pfizer Shots Are Under FDA Review
Via Benzinga
J&J Drops Out Of A Key Race, Leaving Pfizer, GSK, Moderna To Duke It Out
The company says it's refocusing its portfolio to focus on transformational medicines. 
Via Investor's Business Daily
GSK Unveils Detailed Phase 3 Data For Jemperli In Frontline Endometrial Cancer Patients
Via Benzinga
Recent Stock Purchases For March 2023
As readers may know by now, I make stock purchases every single month, no matter what is going on in the world. This month, I went heavier than I normally do, deploying over $3,000. Let's take a look. 
Via Talk Markets
Where Did COVID-19 Really Originate? Biden Signs Bill To Declassify Origins Information
Via Benzinga
Credit Suisse's $17B Of AT1 Debt Written Down To Zero, Richard Branson's Virgin Orbit Plans Insolvency, Court Freezes Volkswagen's Russian Assets: Today's Top Stories
Reuters 
Via Benzinga
Large Vaccine Players Including GSK, Moderna Prepare For Bird Flu Vaccine 'Just In Case'
Via Benzinga
3 Pharma Stocks That Could Benefit from Global Healthcare Trends
The best pharma stocks to buy are those that are poised to be greatly boosted by drugs that are well-positioned to become blockbusters. 
Via InvestorPlace
Better RSV Vaccine Stock: Pfizer, GSK, or Moderna?
An approved RSV vaccine could be the next big thing for these companies. 
Via The Motley Fool
GSK's Chief Scientist Says R&D Focus More On Infectious Disease, HIV Amid Patent Expiration, Dwindling Sales
GSK Plc's (NYSE: GSK) top scientist, Tony Wood, who took the helm of R&D last August, says the R&D department is now delivering results. Wood said he is de-emphasizing R&D in oncology and that the R&D... 
Via Benzinga
3 High Dividend Stocks With Attractive Total Return Potential
In the current economic environment, it is crucial for investors to prioritize quality, reliable dividend stocks and high total returns. 
Via InvestorPlace
Sanofi, AstraZeneca Tee Up A Rival To Pfizer In The Multibillion-Dollar RSV Race
These companies aren't working on a vaccine, but a monoclonal antibody. 
Via Investor's Business Daily
< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
29 30 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.